December 28, 2017
2 min read
Save

Healio Psychiatry revisits top stories of 2017

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

As 2017 comes to an end, Healio Psychiatry put together a list of our most popular stories of the year.

This includes top coverage on research in dementia, pediatrics, depression, ADHD, anxiety, addiction, bipolar depression, suicide, OCD and more.

Depression ranks within top 10 causes of poor health worldwide

The Global Burden of Disease study indicated mental health and substance use disorders were significant causes of poor health across the world, particularly major depressive disorders. Read more.

Trump’s transgender military ban harmful for mental health

President Donald J. Trump indicated a reinstitution of a transgender ban from the military in a series of posts of Twitter. In response, the APA expressed their support of the transgender community via an image on Twitter, which illustrated the harms associated with discrimination and lack of equal rights. Read more.

Monthly buprenorphine depot RBP-6000 effective, safe for opioid addiction

Indivior recently presented phase 3 findings that indicated efficacy and safety of RBP-6000, an investigational once-monthly injectable buprenorphine in the Atrigel delivery system, for treatment of moderate-to-severe opioid use disorder. Read more.

Gun use in IPV has hidden mental health consequences

Recent findings indicated that individuals who experienced intimate partner violence involving a gun were less likely to be physically harmed but more likely to feel frightened, suggesting that this type of violence and trauma could go unnoticed by clinicians. Read more.

FDA approves sNDA for Latuda to treat adolescent schizophrenia

Sunovion recently announced that the FDA approved a supplemental New Drug Application for Latuda for the treatment of schizophrenia in adolescents aged 13 to 17 years. Read more.

Latuda improves bipolar depression in children, adolescents

Data presented at the American Psychiatric Association Annual Meeting indicated Latuda significantly improves depression among children and adolescents, aged 10 to 17 years, with bipolar I depression. Read more.

OCD may hinder performance, success in school

Individuals with obsessive-compulsive disorder performed poorer in school and were less likely to finish upper secondary education, start or finish a university degree and finish a postgraduate degree, particularly if they were diagnosed before age 18 years. Read more.

External trigeminal nerve stimulation effective for pediatric ADHD

Data presented at the American Academy of Child and Adolescent Psychiatry annual meeting indicated efficacy of monotherapy external trigeminal nerve stimulation for ADHD in children. Read more.

APA, AAN update dementia management guidance

The American Psychiatric Association and American Academy of Neurology recently released an updated dementia management quality measurement set, which included three new measures, removed measures and modified measures. Read more.

Comorbid ADHD, conduct disorder explains link between autism, violence

Autism was associated with an increased risk for violent crime; however, the association was significantly attenuated by comorbid ADHD or conduct disorder, according to recent findings. Read more.

Childhood spanking negatively affects adult mental health

Childhood spanking was associated with increased risk for suicide attempts, moderate-to-heavy drinking and illicit drug use in adulthood. Read more.

Suicide assessment must be comprehensive to prevent malpractice

During a presentation at Psych Congress 2017, Phillip J. Resnick, MD, of Case Western Reserve University, outlined how to comprehensively assess patients for suicide risk based on his experience with malpractice lawsuits involving patient suicide. Read more.